Orthopedic Surgery Doctors in American Fork, UT Accepting Medicare

4 Orthopedic Surgery doctors found. Showing 1 - 4

Alan M Banks, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1184 E 80 N, American Fork, UT 84003 Phone: 801-763-3885    Fax: 801-763-3887

Paul K Ritchie, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1184 E 80 N, American Fork, UT 84003 Phone: 801-763-3885    Fax: 801-763-3887

John T Wells, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1184 E 80 N, American Fork, UT 84003 Phone: 801-763-3885    Fax: 801-763-3887

Gordon H Stock, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1184 E 80 N, American Fork, UT 84003 Phone: 801-763-3885    Fax: 801-763-3887

News Archive

Scientists detect molecular obesity link to insulin resistance, type II diabetes

A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.

'Toolkit' for African cancer advocates to be launched on September 15

Cancer kills more than seven million people a year throughout the world. This is more than HIV/AIDS, tuberculosis and malaria combined, and African countries, which carry a large part of the burden, are the least able of all developing countries to cope with the challenges it presents, says a consortium of international cancer organizations.

Study: DBS shows promise for treating patients with post-stroke pain syndrome

Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.

FDA Advisory Committee votes in favor of Vanda's tasimelteon NDA for Non-24-Hour Disorder

Vanda Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee voted overwhelmingly to recommend the approval of Vanda's New Drug Application for tasimelteon, proposed tradename HETLIOZ™, for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.

Study: Atorvastatin reduces inflammation, thrombogenesis in patients with acute ischemic stroke

The population of northeastern China has a high incidence of ischemic stroke. Previous studies have shown that intracranial large-artery atherosclerosis is one of the main causes of ischemic stroke, and that the mechanisms are related to inflammation and thrombosis of the affected arteries.

Read more Medical News

› Verified 7 days ago